An Overview of Novel Adjuvants Designed for Improving Vaccine Efficacy.

导出原文传递

翻译打印收藏纠错

作者： Srinivasa Reddy,Bonam ^[1] ; Charalambos D,Partidos ^[2] ; Sampath Kumar M,Halmuthur ^[3] ; Sylviane,Muller ^[4]

作者单位： CNRS, Immunopathology and therapeutic chemistry/Laboratory of excellence Medalis, Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France; Vaccine Immunology Laboratory, Natural Products Chemistry Division, CSIR-Indian Institute of Chemical Technology, Hyderabad, India. ^[1] CNRS, Immunopathology and therapeutic chemistry/Laboratory of excellence Medalis, Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France. ^[2] Vaccine Immunology Laboratory, Natural Products Chemistry Division, CSIR-Indian Institute of Chemical Technology, Hyderabad, India. Electronic address: sampath@iict.res.in. ^[3] CNRS, Immunopathology and therapeutic chemistry/Laboratory of excellence Medalis, Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France; University of Strasbourg Institute for Advanced Study (USIAS), Strasbourg, France. Electronic address: sylviane.muller@unistra.fr. ^[4]

关键词 CpG ODNs QS-21 delivery systems lipopeptides new adjuvants patents vaccines

主题词佐剂, 免疫(Adjuvants, Immunologic);动物(Animals);人类(Humans);疫苗(Vaccines)

DOI 10.1016/j.tips.2017.06.002

PMID 28668223

发布时间 2018-03-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交